You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Moodys
Dow

Last Updated: April 4, 2020

DrugPatentWatch Database Preview

LEVO-T Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Levo-t patents expire, and what generic alternatives are available?

Levo-t is a drug marketed by Cediprof Inc and is included in one NDA. There is one patent protecting this drug.

This drug has eight patent family members in seven countries.

The generic ingredient in LEVO-T is levothyroxine sodium. There are ten drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.

Drug patent expirations by year for LEVO-T
Drug Prices for LEVO-T

See drug prices for LEVO-T

Pharmacology for LEVO-T
Drug Classl-Thyroxine
Synonyms for LEVO-T
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic aci d, sodium salt
(S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionic Acid Sodium Salt
054I36CPMN
1491-91-4
25416-65-3
3,3',5,5'-Tetraiodo-L-thyronine, sodium salt
50809-32-0
55-03-8
6260AF
A830452
AC-10210
AC-919
AK-46618
AKOS015918420
AKOS024284731
API0007805
BBC/815
Berlthyrox
C08212
C15H10I4NO4.Na
CHEBI:6446
CT-452
CTK4J3191
D-3,5-Diiodo-4-(3',5'-Diiodo-4'-hydroxyphenoxy)-phenylalanine sodium salt
D11113
Dathroid
DTXSID90883228
EBD2201200
Eferox
EINECS 200-221-4
eltroxin
Epitope ID:136776
Euthyrox
FT-0628030
FT-0658959
J-524276
KS-00000F9R
l-Thyroxine monosodium salt
L-Thyroxine sodium
L-Thyroxine sodium salt
L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt
L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodium salt, hydrate (9CI)
L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, monosodiumsalt
L-Tyrosine, O-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-, sodium salt (1:1)
Laevoxin
Letter
Levaxin
Leventa
Levolet
Levoroxine
levothroid
Levothyrox
Levothyroxin-natrium
Levothyroxine sodique
Levothyroxine sodique [INN-French]
Levothyroxine sodium
Levothyroxine Sodium (anhydrous)
Levothyroxine sodium (INN)
Levothyroxine Sodium [USAN:INN]
Levothyroxine Sodium [USAN]
Levothyroxine sodium anhydrous
Levothyroxine sodium tablets
Levothyroxinum natricum
Levothyroxinum natricum [INN-Latin]
levotiroxina de sodio
Levotiroxina sodica
Levotiroxina sodica [INN-Spanish]
Levoxyl
LS-153817
LS-153822
Monosodium L-thyroxine
Novothyrox
NSC 259940
Oroxine
Q27107208
Ro-thyroxine
Roxstan
SCHEMBL34102
SODIUM (2S)-2-AMINO-3-[4-(4-HYDROXY-3,5-DIIODO-PHENOXY)-3,5-DIIODO-PHENYL]PROPANOATE
sodium (2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoate
sodium (2S)-2-azanyl-3-[4-[3,5-bis(iodanyl)-4-oxidanyl-phenoxy]-3,5-bis(iodanyl)phenyl]propanoate
Sodium (S)-2-Amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propionate
sodium 4-o-(4-hydroxy-3,5-diiodophenyl)-3,5-diiodo-l-tyrosine
Sodium l-thyroxin
Sodium L-thyroxine
Sodium levothyroxine
Sodium thyroxin
Sodium thyroxinate
Sodium thyroxine
Sodium-L-thyroxine
Soloxine
ST078859
synthroid
Synthroid sodium
Tetroid
Thevier
Thyradin
Thyradin S
Thyro-Tabs
THYROID
Thyronamin
Thyrosit
Thyroxevan
Thyroxin sodium
Thyroxine sodique
Thyroxine sodium
Thyroxine sodium salt
Thyroxine, monosodium salt, L-
Thyroxinique
Thyroxinum natricum
Tiroidina
Tirosint
Tirosint-Sol
Tyrosint
UNII-054I36CPMN
Unithroid
YDTFRJLNMPSCFM-YDALLXLXSA-M
Z2798529463

US Patents and Regulatory Information for LEVO-T

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-001 Mar 1, 2002 AB1,AB2,AB3 RX No No   Start Trial   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-007 Mar 1, 2002 AB1,AB2,AB3 RX No No   Start Trial   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-004 Mar 1, 2002 AB1,AB2,AB3 RX No No   Start Trial   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-011 Mar 1, 2002 AB1,AB2,AB3 RX No No   Start Trial   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-012 Dec 8, 2003 AB1,AB2,AB3 RX No No   Start Trial   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-002 Mar 1, 2002 AB1,AB2,AB3 RX No No   Start Trial   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-003 Mar 1, 2002 AB1,AB2,AB3 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LEVO-T

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-009 Mar 1, 2002   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-001 Mar 1, 2002   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-005 Mar 1, 2002   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-011 Mar 1, 2002   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-008 Mar 1, 2002   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-006 Mar 1, 2002   Start Trial   Start Trial
Cediprof Inc LEVO-T levothyroxine sodium TABLET;ORAL 021342-007 Mar 1, 2002   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Johnson and Johnson
AstraZeneca
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.